These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3898859)

  • 1. Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.
    Timens W; Poppema S
    Am J Pathol; 1985 Sep; 120(3):443-54. PubMed ID: 3898859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal and neonatal development of human spleen: an immunohistological study.
    Timens W; Rozeboom T; Poppema S
    Immunology; 1987 Apr; 60(4):603-9. PubMed ID: 3294575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response.
    Timens W; Boes A; Rozeboom-Uiterwijk T; Poppema S
    J Immunol; 1989 Nov; 143(10):3200-6. PubMed ID: 2478621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of subpopulations of T lymphocytes in Hodgkin's disease.
    Gulwani BN; Advani SH; Gangal SG
    Neoplasma; 1985; 32(2):239-46. PubMed ID: 3873623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal zones: the major B cell compartment of rat spleens.
    Kumararatne DS; Bazin H; MacLennan IC
    Eur J Immunol; 1981 Nov; 11(11):858-64. PubMed ID: 6976894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
    Kharabadze MV; Tabagari DZ
    Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
    Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
    Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of blood, spleen and recirculating lymphocytes in man.
    Reinecke G; Pabst R
    Clin Exp Immunol; 1983 Sep; 53(3):672-8. PubMed ID: 6225579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.
    Miyawaki T; Ohzeki S; Ikuta N; Seki H; Taga K; Taniguchi N
    J Immunol; 1984 Dec; 133(6):2996-3000. PubMed ID: 6092463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
    Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
    Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
    Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
    Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.
    Souhami RL; Babbage J; Sigfusson A
    Clin Exp Immunol; 1983 Aug; 53(2):297-307. PubMed ID: 6309443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responsiveness in Hodgkin's disease.
    Denton PM
    Br J Cancer Suppl; 1973 Aug; 1():119-27. PubMed ID: 4613371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.